Therefore, in the present study, we sought to investigate the significance of NT pro-BNP, hs-CRP and big-ET levels in hospitalized patients with DCM and to test the hypothesis that the three biomarkers could be prognostic markers of all-cause mortality in these patients. The gene discussed is NPPB; the disease is familial dilated cardiomyopathy.